Given that our CM boosted macrophage phagocytosis and increased the expression of CD206 and CD163 while decreasing the level of HLA-DR and CD86, CM treatment for cisplatin-induced AKI might be beneficial to prevent the progression of renal fibrosis in vivo. Here, CD163 is linked to acute kidney injury.